5-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)-2-(三氟甲基)吡啶, 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoro

2,6-双((4S,5R)-4,5-二氢-4,5-二苯基噁唑-2-基)吡啶, 2,6-Bis((4S,5R)-4,5-dihydro-4,5-diphenyloxazol-2-yl)pyridine

利奈唑胺杂质33, Linezolid Impurity 33

(2R,4R)-1-(叔丁氧基羰基)-4-甲基吡咯烷-2-羧酸, (2R,4R)-1-(tert-Butoxycarbonyl)-4-methylpyrrolidine-2-carbox

4-氧代四氢-2H-吡喃-2-羧酸乙酯, Ethyl 4-oxooxane-2-carboxylate

(11bS)-8,9,10,11,12,13,14,15-八氢-N,N-双[(1R)-1-苯乙基]-联萘并[2,1-d:1',2'-f][1,3,2]二氧杂膦-4-胺, (11bS)-8,9,10,11,12,13,14,15-Octahydro-N,N-bis[(1

3-(二甲基氨基)-1-苯基-2-丙烯-1-酮, 3-(Dimethylamino)-1-phenyl-2-propen-1-one

(4S,5S)-2,2-二甲基-1,3-二氧戊环-4,5-二甲酸二乙酯, Diethyl (4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate

左卡尼汀杂质C, Levocarnitine EP Impurity C Chloride

3-氨基-2-溴-6-氯吡啶, 2-Bromo-6-chloropyridin-3-amine